Shukla AP - Search Results

1

Five-year Weight Loss Maintenance With Obesity Pharmacotherapy.

Weintraub MA, D'Angelo D, Tchang BG, Sahagun AD, Andre C, Aronne LJ, Shukla AP. Weintraub MA, et al. Among authors: shukla ap. J Clin Endocrinol Metab. 2023 Aug 18;108(9):e832-e841. doi: 10.1210/clinem/dgad100. J Clin Endocrinol Metab. 2023. PMID: 36810608 Free PMC article.

2

Initial experience with endoscopic sleeve gastroplasty: technical success and reproducibility in the bariatric population.

Sharaiha RZ, Kedia P, Kumta N, DeFilippis EM, Gaidhane M, Shukla A, Aronne LJ, Kahaleh M. Sharaiha RZ, et al. Endoscopy. 2015 Feb;47(2):164-6. doi: 10.1055/s-0034-1390773. Epub 2014 Nov 7. Endoscopy. 2015. PMID: 25380510

3

Treatment of obesity in 2015.

Shukla AP, Buniak WI, Aronne LJ. Shukla AP, et al. J Cardiopulm Rehabil Prev. 2015 Mar-Apr;35(2):81-92. doi: 10.1097/HCR.0000000000000112. J Cardiopulm Rehabil Prev. 2015. PMID: 25714749 Review.

4

Metreleptin and generalized lipodystrophy and evolving therapeutic perspectives.

Tchang BG, Shukla AP, Aronne LJ. Tchang BG, et al. Among authors: shukla ap. Expert Opin Biol Ther. 2015 Jul;15(7):1061-75. doi: 10.1517/14712598.2015.1052789. Expert Opin Biol Ther. 2015. PMID: 26063386 Review.

5

Food Order Has a Significant Impact on Postprandial Glucose and Insulin Levels.

Shukla AP, Iliescu RG, Thomas CE, Aronne LJ. Shukla AP, et al. Diabetes Care. 2015 Jul;38(7):e98-9. doi: 10.2337/dc15-0429. Diabetes Care. 2015. PMID: 26106234 Free PMC article. No abstract available.

6

Lorcaserin Hcl for the treatment of obesity.

Shukla AP, Kumar RB, Aronne LJ. Shukla AP, et al. Expert Opin Pharmacother. 2015;16(16):2531-8. doi: 10.1517/14656566.2015.1096345. Epub 2015 Oct 15. Expert Opin Pharmacother. 2015. PMID: 26472579 Review.

7

Response to Comment on Shukla et al. Food Order Has a Significant Impact on Postprandial Glucose and Insulin Levels. Diabetes Care 2015;38:e98-e99.

Shukla AP, Aronne LJ. Shukla AP, et al. Diabetes Care. 2015 Nov;38(11):e197. doi: 10.2337/dci15-0010. Diabetes Care. 2015. PMID: 26494819 No abstract available.

8

Bupropion-SR plus naltrexone-SR for the treatment of mild-to-moderate obesity.

Ali KF, Shukla AP, Aronne LJ. Ali KF, et al. Among authors: shukla ap. Expert Rev Clin Pharmacol. 2016;9(1):27-34. doi: 10.1586/17512433.2016.1100072. Epub 2015 Oct 29. Expert Rev Clin Pharmacol. 2016. PMID: 26512740 Review.

9

Pharmacotherapy for Obesity.

Saunders KH, Shukla AP, Igel LI, Kumar RB, Aronne LJ. Saunders KH, et al. Among authors: shukla ap. Endocrinol Metab Clin North Am. 2016 Sep;45(3):521-38. doi: 10.1016/j.ecl.2016.04.005. Endocrinol Metab Clin North Am. 2016. PMID: 27519128 Review.

10

Low adoption of weight loss medications: A comparison of prescribing patterns of antiobesity pharmacotherapies and SGLT2s.

Thomas CE, Mauer EA, Shukla AP, Rathi S, Aronne LJ. Thomas CE, et al. Among authors: shukla ap. Obesity (Silver Spring). 2016 Sep;24(9):1955-61. doi: 10.1002/oby.21533. Obesity (Silver Spring). 2016. PMID: 27569120 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

76 results

Search Page